CATALYST PHARMACEUTICALS, INC. (CPRX) › Operating IncomeCATALYST PHARMACEUTICALS, INC. (CPRX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$7.28M2010: -$4.02M2011: -$6.08M2012: -$5.22M2013: -$10.31M2014: -$14.59M2015: -$20.40M2016: -$19.28M2017: -$18.68M2018: -$35.30M2019: $31.82M2020: $41.30M2021: $52.38M2022: $101.84M2023: $86.81M2024: $195.12M2025: $257.78M$257.78M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$257.78M+32.1%2024$195.12M+124.8%2023$86.81M-14.8%2022$101.84M+94.4%2021$52.38M+26.8%2020$41.30M+29.8%2019$31.82M+190.2%2018-$35.30M-88.9%2017-$18.68M+3.1%2016-$19.28M+5.5%2015-$20.40M-39.8%2014-$14.59M-41.5%2013-$10.31M-97.5%2012-$5.22M+14.2%2011-$6.08M-51.1%2010-$4.02M+44.7%2009-$7.28M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share